CSL112 Increases Plasma Cholesterol Efflux Capacity and Reduces Erythrocyte Membrane Cholesterol Content in Blood Samples from Patients with Sickle Cell Disease

被引：1
|
作者：
Didichenko, Svetlana [1 ]
Navdaev, Alexey [1 ]
Saxenhofer, Moritz [2 ]
Graeter, Stefanie [2 ]
Schaub, Alexander [2 ]
Rovo, Alicia [3 ,4 ]
Kato, Gregory J. [5 ,6 ,7 ,8 ]
Kingwell, Bronwyn [9 ]
机构：
[1] CSL Behring AG, Bern, Switzerland
[2] CSL Behring AG, Res & Dev, Bern, Switzerland
[3] Univ Bern, Univ Hosp Bern, Inselspital, Dept Hematol, Bern, Switzerland
[4] Univ Bern, Univ Hosp Bern, Inselspital, Cent Hematol Lab, Bern, Switzerland
[5] Univ Pittsburgh Phys, Tilghman, MD USA
[6] CSL Behring, Clin Res & Dev, King Of Prussia, PA USA
[7] Univ Mississippi, Med Ctr, Dept Med, Hematol & Oncol, Jackson, MS 39216 USA
[8] Univ Pittsburgh Phys, Pittsburgh, PA USA
[9] CSL Ltd, Parkville, Vic, Australia
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158405
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2528 / 2529
页数：2
相关论文
共 10 条
  • [1] CSL112 robustly enhances the ability of serum to efflux cholesterol in normal healthy adults and patients with atherothrombotic disease
    Gille, A.
    D'Andrea, D.
    Hartel, G.
    Easton, R.
    Wright, S. D.
    Shear, C. L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1154 - 1154
  • [2] CSL112, A NOVEL FORMULATION OF HUMAN APOA-I, RAPIDLY ENHANCES CHOLESTEROL EFFLUX CAPACITY OF PLASMA FOLLOWING INFUSION
    Easton, Rachael
    Diditchenko, Svetlana
    Spycher, Martin
    Waelchli, Marcel
    Imboden, Martin
    Schenk, Sabrina
    Pragst, Ingo
    Wright, Samuel D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E491 - E491
  • [3] Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients
    Zheng, Bo
    Duffy, Danielle
    Tricoci, Pierluigi
    Kastrissios, Helen
    Pfister, Marc
    Wright, Samuel D.
    Gille, Andreas
    Tortorici, Michael A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2558 - 2571
  • [4] CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients
    Gille, Andreas
    D'Andrea, Denise
    Tortorici, Michael A.
    Hartel, Gunter
    Wright, Samuel D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (04) : 953 - 963
  • [5] CSL112 (APOLIPOPROTEIN A-I [HUMAN]) SIMILARLY ENHANCES CHOLESTEROL EFFLUX CAPACITY IN JAPANESE AND CAUCASIAN SUBJECTS: FINDINGS FROM A PHASE 1 STUDY
    Tortorici, Michael
    Clementi, Regina
    Feaster, John
    Zheng, Bo
    Duffy, Danielle
    Dalitz, Penelope
    Airey, Jolanta
    Roberts, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 131 - 131
  • [6] Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison
    Zheng, Bo
    Goto, Shinya
    Clementi, Regina
    Feaster, John
    Duffy, Danielle
    Dalitz, Penelope
    Airey, Jolanta
    Korjian, Serge
    Tortorici, Michael A.
    Roberts, John
    Gibson, C. Michael
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (10): : 2331 - 2341
  • [7] CSL112, A Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Patients With Stable Atherothrombotic Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study
    Gille, Andreas
    D'Andrea, Denise
    Easton, Rachel
    Tricoci, Pierluigi
    Alexander, John H.
    Wright, Samuel D.
    Shear, Charles L.
    CIRCULATION, 2013, 128 (22)
  • [8] CSL112, a Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Healthy Subjects: A, Placebo-Controlled, Double-Blinded, Randomized Single Ascending Dose Study
    Gille, Andreas
    Easton, Rachael
    Wright, Samuel
    Shear, Charles
    CIRCULATION, 2012, 126 (21)
  • [9] CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial
    Gibson, C. Michael
    Kazmi, Syed Hassan A.
    Korjian, Serge
    Chi, Gerald
    Phillips, Adam T.
    Montazerin, Sahar Memar
    Duffy, Danielle
    Zheng, Bo
    Heise, Mark
    Liss, Charles
    Deckelbaum, Lawrence I.
    Wright, Samuel D.
    Gille, Andreas
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [10] Red blood cell distribution width - a strong prognostic marker in cardiovascular disease - is associated with cholesterol content of erythrocyte membrane
    Tziakas, Dimitrios
    Chalikias, Georgios
    Grapsa, Anastasia
    Gioka, Theodora
    Tentes, Ioannis
    Konstantinides, Stavros
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2012, 51 (04) : 243 - 254
1